Women who used fertility treatments had no higher overall risk of invasive cancer than other women, a large Australian study led by researchers from UNSW Sydney has found. The study, published in JAMA ...

The discrepancy isn't just in the rate of occurrence — it’s also caused by tumor location.

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

Colorectal cancer rates are rising among young people in the U.S. One woman diagnosed at 32 shares the subtle early symptoms ...

Women have a 12.9% — or about 1 in 8 — chance of contracting breast cancer during their lifetime, according to the National Cancer Institute. While breast cancer risk increases with age, a 2024 ...

Nearly 1 in 4 cancers detected at a community breast imaging center were in women younger than 50. Learn the risks and how to protect yourself. A new study found that nearly 1 in 4 breast cancers ...

CANCER AWARENESS MONTH COVERAGE. THE RATE OF BREAST CANCER HAS BEEN INCREASING BY 1% PER YEAR SINCE THE MID 2000, AND MEDICAL EXPERTS SAY THEY’RE SEEING IT MORE IN YOUNGER WOMEN, AND THAT COULD BE DUE ...

New research indicates that a long-maligned menopausal treatment is safer than previously thought, showing that it doesn’t increase breast cancer risk in women with inherited mutations in the BRCA1 or ...

Anjali Patel speaks with two Las Vegas survivors who are sharing their stories and working to educate other women about early detection LAS VEGAS (KTNV) — This Breast Cancer Awareness Month, I want to ...

A major step in prevention is the Human Papillomavirus (HPV) vaccine. While initially developed and available primarily ...

Please provide your email address to receive an email when new articles are posted on . Use of vaginal estrogen therapy does not affect recurrence risk for women previously diagnosed with endometrial ...

This is less than a year after the Teal Wand from Teal Health became the first at-home cervical cancer screening test approved by the U.S. Food and Drug Administration.